Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). SHOW MORE
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: may 16, 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) More information
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: September 20, 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract...
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: February 27, 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™ More information
+ UDIBI admin_udibi3, 29 de August de 202329 de August de 2023, 2023, Uncategorized, 0 An international comparative analysis and roadmap to sustainable biosimilar markets. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...